Aptose Biosciences Inc. (TSE:APS - Get Free Report) NASDAQ: APTO's share price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$1.76 and traded as high as C$1.79. Aptose Biosciences shares last traded at C$1.58, with a volume of 1,300 shares trading hands.
Aptose Biosciences Stock Performance
The company has a debt-to-equity ratio of -117.37, a current ratio of 1.05 and a quick ratio of 5.41. The company has a market capitalization of C$68.89 million, a price-to-earnings ratio of -0.32 and a beta of 1.36. The stock has a 50 day simple moving average of C$1.75 and a two-hundred day simple moving average of C$3.10.
Aptose Biosciences Company Profile
(
Get Free Report)
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Recommended Stories
Before you consider Aptose Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aptose Biosciences wasn't on the list.
While Aptose Biosciences currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access